About Jeffrey Weedman
Form D filings for Sus Clinicals in 2024 list Jeffrey Weedman as executive officer and director.
Jeffrey Weedman first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Jeffrey Weedman in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jeffrey Weedman works with at each company, as listed on that company's latest Form D.
Sus Clinicals, Inc. · Form D, Jan 10, 2024
SB
Stephen Baggott
Executive officer and director
GM
Geoffrey Marshall
Executive officer and director